Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan’s MHLW Encourages Hospitals To Embrace Treatment-specific Reimbursement System

This article was originally published in PharmAsia News

Executive Summary

TOKYO - By July 2009, a total of 1,383 Japanese hospitals, out of some 9,000 hospitals in the country, will be recognized by Japan's Ministry of Health, Labor and Welfare as medical facilities to be evaluated by a "diagnosis procedure combination," similar to the U.S. diagnosis-related group system, to receive fixed-sum National Health Insurance reimbursements for treatments in MHLW-specified disease groups, an MHLW official told PharmAsia News April 6

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071561

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel